Skye Bioscience, Inc. (SKYE) Net income 2016–2025
Skye Bioscience, Inc. (SKYE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$55.9MFY2025 · since FY2016: -$3.2M → -$55.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$55.9M | -110.5% |
| FY2024 | -$26.6M | +29.4% |
| FY2023 | -$37.6M | -93.2% |
| FY2022 | -$19.5M | -128.6% |
| FY2021 | -$8.5M | -29.9% |
| FY2020 | -$6.6M | -723.7% |
| FY2019 | $1.1M | +105.5% |
| FY2018 | -$19.2M | -520.3% |
| FY2017 | -$3.1M | +2.6% |
| FY2016 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SKYE financial trends
SKYE RevenueSKYE Net marginSKYE Gross profitSKYE Gross marginSKYE Operating incomeSKYE Operating marginSKYE Operating cash flowSKYE Free cash flowSKYE Capital expendituresSKYE Return on equitySKYE Stock buybacksSKYE Dividends paidSKYE Total assetsSKYE Total liabilitiesSKYE Shareholders’ equitySKYE overview →